Continuation of clozapine following mild myocarditis

Australian and New Zealand Journal of Psychiatry

Volumn 46, Issue 9, 2012, Pages 910-911

  Ronaldson, Kathlyn J ^a   Fitzgerald, Paul B ^b   Taylor, Andrew J ^c   McNeil, John J ^a  

^a MONASH UNIVERSITY   (Australia)

^b Alfred Hospital ^*  (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CLOZAPINE; TROPONIN I; TROPONIN T; NEUROLEPTIC AGENT;

ADULT; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG DOSE REDUCTION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; LETTER; LONG TERM CARE; MALE; MENTAL HEALTH; MYOCARDITIS; PATIENT MONITORING; TACHYCARDIA; TREATMENT INDICATION; CASE REPORT; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PSYCHOSIS;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDITIS; PSYCHOTIC DISORDERS;

EID: 84873738681     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867411433970     Document Type: Letter

References (3)

1. Ronaldson KJ, Taylor AJ, Fitzgerald PB, et al. Diagnostic characteristics of clozapine induced myocarditis identified by an analysis of 38 cases and 47 controls. Journal of Clinical Psychiatry. 2010 ; 71: 976-981
2. Ronaldson KJ, Taylor AJ, Fitzgerald PB, et al. Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases. Schizophrenia Research. 2011a ; 128: 161-165
3. Ronaldson KJ, Taylor AJ, Fitzgerald PB, et al. A new monitoring protocol for clozapine induced myocarditis based on an analysis of 75 cases and 94 controls. Australian and New Zealand Journal of Psychiatry. 2011b ; 45: 458-465